21:34 , May 28, 2019 |  BC Extra  |  Financial News

May 28 Financial Quick Takes: Alphamab Oncology raises $60M; plus $180.5M for Panacea healthcare fund and more

Hudson Bay leads Alphamab Oncology's $60M series B Alphamab Oncology (Cayman) raised $60 million in a series B round led by Hudson Bay Capital, with participation from new investor and entrepreneur Adrian Cheng and existing...
20:04 , Apr 25, 2019 |  BC Innovations  |  Finance

The academic founders' conundrum

First-time academic entrepreneurs face a circular problem: while they’re continually sought after by VCs and pharmas seeking the next “big thing”, they also face an arduous path to establish their bona fides - not for...
18:40 , Mar 12, 2019 |  BC Extra  |  Financial News

InventisBio raises $70M series C to advance early stage pipeline

InventisBio raised $70 million in a series C round led by Advantech Capital and CMBI, the Chinese biotech announced late Monday. Pudong Innotek and existing investors Lilly Asia Ventures and OrbiMed Asia also participated in...
04:00 , Jan 4, 2019 |  BC Week In Review  |  Financial News

Suzhou Connect raises $55M series B, plans Phase Ib of dermatitis candidate

Suzhou Connect Biopharmaceuticals Ltd. (Taicang, China) raised $55 million on Jan. 2 in a series B round led by new investor Advantech Capital and announced plans to start a Phase Ib trial this quarter of...
01:06 , Jan 3, 2019 |  BC Extra  |  Financial News

Suzhou Connect raises $55M series B, plans Phase Ib of dermatitis candidate

Suzhou Connect Biopharmaceuticals Ltd. (Taicang, China) raised $55 million in a series B round Wednesday led by new investor Advantech Capital and announced plans to start a Phase Ib trial this quarter of its second...
19:41 , Nov 21, 2018 |  BioCentury  |  Finance

Alphamab's cancer cash

Alphamab Oncology spun out from Suzhou Alphamab Co. Ltd. and raised more than $100 million in a series A round to advance multiple cancer biologics through clinical testing. Investors in the round, which closed on...
23:22 , Nov 16, 2018 |  BC Extra  |  Financial News

Alphamab Oncology raises more than $100M series A

Immuno-oncology company Alphamab Oncology (Cayman) raised over $100 million in a series A round to accelerate development of its biologics including lead product KN035. Advantech Capital, PAG, China Venture Capital Fund, OrbiMed Advisors, Heritage Provider...
18:58 , Jul 13, 2018 |  BC Week In Review  |  Financial News

Sinovac Terminates Take-Private Deal, Raises $86.7M

Vaccines company Sinovac Biotech Ltd. (NASDAQ:SVA) said July 3 it raised $86.7 million in a private placement and terminated a planned deal to take the company private. A special committee formed by the company's board...
18:09 , Jul 3, 2018 |  BC Extra  |  Financial News

Sinovac terminates take-private deal, raises $86.7M

Vaccines company Sinovac Biotech Ltd. (NASDAQ:SVA) said it raised $86.7 million in a private placement and terminated a planned deal to take the company private. A special committee formed by the company's board determined that...
19:25 , Jan 26, 2018 |  BC Week In Review  |  Financial News

Harbour BioMed raises undisclosed series A+

Harbour BioMed (Shanghai, China) raised an undisclosed series A+ round on Jan. 22 led by new investor CDH Investments. Existing investor Advantech Capital participated. This month, Harbour granted BeiGene Ltd. (NASDAQ:BGNE) and ImmunoChina Pharmaceuticals Co....